Magnesium deficiency upregulates serine palmitoyl transferase (SPT 1 and SPT 2) in cardiovascular tissues: Relationship to serum ionized Mg and cytochrome c

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 3, 2010, Pages

  Altura, Burton M ^a,c,d   Shah, Nilank C ^a   Li, Zhiqiang ^b   Jiang, Xian Cheng ^b   Perez Albela, Jose Luis ^e   Altura, Bella T ^a,c,d  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Downstate Health Sciences University   (United States)

^d Rockville Centre   (United States)

^e Instituto Bien de Salud   (Peru)

Author keywords

Apoptosis; Cardiac muscles; Ceramides; Sphingomyelin; Vascular smooth muscle

Indexed keywords

CERAMIDE; CYTOCHROME C; MAGNESIUM ION; SERINE PALMITOYLTRANSFERASE; SERINE PALMITOYLTRANSFERASE 1; SERINE PALMITOYLTRANSFERASE 2; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; MAGNESIUM;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVATION; FEMALE; HEART ATRIUM MUSCLE; HEART LEFT VENTRICLE MUSCLE; HEART PROTECTION; HEART RIGHT VENTRICLE; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; HEART MUSCLE; METABOLISM; REGRESSION ANALYSIS; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CERAMIDES; CYTOCHROMES C; FEMALE; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; RATS; RATS, WISTAR; REGRESSION ANALYSIS; SERINE C-PALMITOYLTRANSFERASE; SPHINGOMYELINS; UP-REGULATION;

EID: 77956694490     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01076.2009     Document Type: Article

References (65)

1. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 41: 347-359, 1995.
2. Altura BM, Altura BT. Magnesium: forgotten mineral in cardiovascular biology and atherogenesis. In: New Perspectives in Magnesium Research, edited by Nishizawa N, Morii H, and Durlach J. New York: Springer, 2007, p. 239-260.
3. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Science 223: 1315-1317, 1984. (Pubitemid 14163190)
4. Altura BM, Gebrewold A, Zheng T, Altura BT. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: insight into mechanisms and possible relation to brain injury and stroke. Brain Res Bull 58: 271-278, 2002.
5. 2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis and stroke. Am J Hypertens 16: 701-707, 2003.
6. Altura BM, Shah NC, Jiang XC, Li Z, Perez-Albela JL, Sica AC, Altura BT. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. Am J Physiol Heart Circ Physiol 297: H86-H92, 2009.
7. Altura BT, Altura BM. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. Magnes Trace Elem 10: 90-98, 1991.
8. Altura BT, Brust M, Barbour RL, Stempak J, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA 87: 1840-1844, 1990.
9. Altura BT, Memon ZI, Zhang A, Cracco RQ, Altura BM. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation of cytosolic free calcium and spasm in cerebral vascular smooth muscle cells. Neurosci Lett 230: 37-40, 1997.
10. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 130: 1871-1877, 2000.
11. Chipperfield B, Chipperfield JR. Relation of myocardial metal concentrations to water hardness and death from ischemic heart disease. Lancet 2: 709-712, 1979. (Pubitemid 10210199)
12. Djurhuus S, Henriksen JE, Klitgaard NA, Blaabjerg O, Thye-Ron P, Altura BM, Altura BT, Beck-Nielsen H. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care 22: 546-554, 1999.
13. Durlach J, Bara M, Guiet-Bara A. Magnesium level in drinking water and cardiovascular risk factor: a hypothesis. Magnesium 4: 5-15, 1985.
14. Eisenberg MJ. Magnesium deficiency and sudden death. Am Heart J 124: 544-549, 1992.
15. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 133: 2879-2882, 2003.
16. Grant S, Spiegel S. A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKC? J Clin Invest 109: 717-719, 2002. (Pubitemid 34263147)
17. Hanada N. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 1632: 16-30, 2003.
18. Hanada K, Hara T, Nishikjima m Kuge O, Dickson RC, Nagiec MM. A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis. J Biol Chem 272: 32108-32114, 1997.
19. Handwerker SM, Altura BT, Royo B, Altura BT. Ionized magnesium and calcium levels in umbilical cord blood of pregnant women with transient hypertension during labor. Am J Hypertens 6: 542-545, 1993. (Pubitemid 23179504)
20. Handwerker SM, Altura BT, Altura BM. Serum ionized magnesium and other electrolytes in the antenatal period of human pregnancy. J Am Coll Nutr 15: 36-43, 1996.
21. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125-3128, 1994.
22. Hannun YA. Functions of ceramide in coordinating response to stress. Science 274: 1855-1859, 1996.
23. Hojjati MR, Li Z, Jiang XC. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim Biophys Acta 1737: 44-51, 2005.
24. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 361: 1570-1583, 2009.
25. Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin M, Berglund L, Tall AR. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 20: 2614-2618, 2000.
26. Kobayashi J. On geographical relationship between the chemical nature of river water and death from apoplexy. Berichte des Ohara Inst fur Landwirtsch Biol 11: 12-21, 1957.
27. Kolesnick R. Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 21: 287-297, 1994. (Pubitemid 24174527)
28. Krysko DV, Kaczmarek A, Vandenbeele P. Molecular pathways of different types of cell death: Many roads to cell death. In: Phagocytosis of Dying Cells: From Molecular Mechanisms to Human Disease, edited by Krysko DV and Vandenabeele P. New York: Springer, 2009, p. 4-31.
29. Leary WP. Content of magnesium in drinking water and deaths from ischemic heart disease in White South Africans. Magnesium 5: 150-153, 1986.
30. i in rat aortic smooth muscle cells: possible role of extracellular and intracellular magnesium ions in peroxynitrite-induced cell death. Drug Metab Lett 1: 85-89, 2007.
31. Li Z, Hailemariam TK, Zhou H, Li Y, Duckworth DC, Peake DA, Zhang Y, Kuo MS, Cao G, Jiang XC. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim Biophys Acta 1771: 1186-1194, 2007.
32. Marier JH, Neri LC. Quantifying the role of magnesium in the interrelationship between human motality/morbidity and water hardness. Magnesium 4: 53-59, 1985.
33. Marx A, Neutra RR. Magnesium in drinking water and deaths from ischemic heart disease. Epidemiol Rev 19: 258-272, 1997.
34. Merrill AH Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 277: 25843-25846, 2002.
35. Merrill AH Jr, Jones DD. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta 1044: 1-12, 1990.
36. Mimouni FB. The ion-selective magnesium electrode: a new tool for clinicians and investigators. J Am Coll Nutr 15: 4-5, 1996.
37. 2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett 408: 191-194, 1997.
38. 2+ modulates membrane sphingolipids and lipid second messenger levels in vascular smooth muscle cells. FEBS Lett 440: 167-171, 1998.
39. Muneyyirici-Delale O, Nacharaju VL, Jalou S, Rahman M, Altura BM, Altura BT. Divalent cations in PCOS: implications for cardiovascular disease. Gynecol Endocrinol 15: 198-201, 2001.
40. Panday S, Murphy RF, Agrawal DK. Recent advances in the immunobiology of ceramide. Exp Mol Pathol 82: 298-309, 2007.
41. Perry DK, Carton J, Shah AK, Meredith F, Uhlinger DJ, Hannun YA. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275: 9078-9084, 2000. (Pubitemid 30180269)
42. Putcha GV, Deshmukh M, Johnson EM Jr. Inhibition of apoptotic signaling cascade causes loss of trophic factor dependence during neuronal. J Cell Biol 149: 1011-1018, 2000.
43. Quillet J, Kilkus J, McShan CL, Gottschalk AR, Dawson G. Ceramide mediates the apoptotic response of WEH 231 cells to anti-immunoglobin, corticosteroids and irradiation. Biochem Biophys Res Commun 202: 710-714, 1994. (Pubitemid 24259272)
44. 2-ceramide: protection by exogenous phosphatidylcholine. Neuroreport 11: 3103-3108, 2000.
45. Rayssiguier Y, Gueux E. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 5: 507-519, 1986.
46. Resnick LM, Bardicef D, Altura BT, Alderman MH, Altura BM. Serum ionized magnesium: relation to blood pressure and racial factors. Am J Hypertens 10: 1420-1424, 1997.
47. Rubenowitz E, Molin I, Axelsson G, Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiology 11: 416-421, 2003.
48. Saris NE, Mervaala E, Karppanen H. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chem Acta 294: 1-26, 2000. (Pubitemid 30155803)
49. Scott VL, De Wolf AM, Kang Y, Altura BT, Virji MA, Cook DR, Altura BM. Ionized hypomagnesemia in patients ubdergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg 2: 343-347, 1996.
50. Schroeder HA. Relations between hardness of water and death rates from certain chronic and degenerative diseases in the United States. J Chronic Dis 12: 586-591, 1960.
51. Singh RB. Magnesium status and risk of coronary artery disease in rural and urban populations with variable magnesium consumption. Magnes Res 1: 205-213, 1997.
52. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 316: 25-28, 1996. (Pubitemid 26158197)
53. Soliman HM, Mercan D, Lobo SS, Melot C. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 31: 1082-1987, 2003.
54. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 208: 198-200, 1980.
55. Vaandrager AB, Houweling M. Effect of ceramides on phospholipid biosynthesis and its implications for apoptosis. In: Phospholipid metabolism in Apoptosis, edited by Quinn PJ and Kagan VE. New York: Kluwer Academic, 2002, p. 207-227.
56. Weglicki WB, Mak IT, Dickens BF, Stafford RE, Komarov AM, Gibson B, Cassidy MM, Phillips TM, Kramer JH. Neuropeptides, free radical stress and antioxidants in models of Mg-deficient cardiomyopathy. In: Magnesium: Current Status and New Developments, edited by Theophanides T and Anastassopolou J. London: Kluwer Academic, 1997, p. 169-178.
57. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 118: 105-111, 1992.
58. Weiss B, Stoffel W. Human and murine serine-palmitoyl-CoA transferase- cloning, expression and characterization of the key enzyme in sphingolipid synthesis. Eur J Biochem 249: 239-247, 1997.
59. Wilkes NJ, Mallet S, Peachey T, Di Salvo C. Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 95: 828-834, 2002.
60. Williams RD, Sgoutas DS, Zaatari GS. Enzymology of long-chain base synthesis by aorta: induction of serine palmitoyltransferase in rabbit aorta during atherogenesis. J Lipid Res 27: 763-770, 1986.
61. Wu F, Altura BT, Gao J, Barbour RL, Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta 1225: 158-164, 1994. (Pubitemid 24033276)
62. Wymann M, Schneiter R. Lipid signaling in disease. Nat Rev Mol Cell Biol 9: 162-176, 2008.
63. Yasuda S, Nishijima M, Hanada K. Localization topology, and function of the LCB 1 subunit of serine palmitoyltransferase in mammalian cells. J Biol Chem 278: 4176-4183, 2003.
64. Zehtabchi S, Sinert R, Runnert S, Chang B, Heinis C, Altura RA, Altura BT, Altura BM. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients and sickle cell anemia. Am J Hematol 77: 1-8, 2004.
65. i in canine cerebral vascular muscle. Am J Physiol Heart Circ Physiol 278: H1421-H1428, 2000.